Defining the signaling events that lead to loss of tolerance is critical for understanding autoimmunity. Loss of regulatory T (Treg) cells caused by deficiency of Foxp3, which is a master transcription factor that controls Treg cell development and function, results in fatal autoimmune diseases in both mouse and human. [1] [2] [3] Thus the precise regulation of Treg cells, which play a critical role in controlling excessive host response and preventing autoimmunity, 4 needs to be fully defined.
Cytokines can be critical for Treg cell development and function. TGF-β is important in inducing Treg cells from conventional CD4
+ T cells as well as Treg development in thymus, while IL-2 maintains TGF-β induced Treg cell stability in vivo. [5] [6] [7] TGF-β signaling deficiency results in Akt hyperactivation of thymus Treg cells, which converts Treg cells to a Th1 phenotype and decreased their stability intrinsically. 8 On the other hand, IL-2 can induce the phosphorylation of STAT5, which is important in induction and maintenance of Foxp3 expression and expanding Treg cells. 9 dnTGF-βRII mice, which express a dominant-negative form of the TGF-β receptor type II under the control of the murine CD4 promoter, develop inflammatory infiltration due to T cell hyperactivation. 10 Treg cells from dnTGF-βRII mice are less capable of suppressing T cell activation in vitro.
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Il2ra
− / − mice develop autoimmune disorders due to dysregulated Treg cells and polyclonal T and B-cell expansion. 12, 13 Although plenty of work have revealed the role of cytokines TGF-β and IL-2 on Treg cells, how they combine to contribute to Treg development in the thymus and maintenance in the periphery needs to be clearly clarified.
In this study, we investigated the synergetic role of TGF-β and IL-2 on Treg cells by crossing dnTGF-βRII mice with Il2ra − / − mice to generate Il2ra − / − Tg mice, in which TGF-β and IL-2 signaling were both blocked in T cells. Il2ra − / − Tg mice but not control mice, developed multi-organ autoimmune diseases at 3-4 weeks after birth due to dysregulation of Treg cells. TGF-β and IL-2 synergistically influenced the development, activation and stability of both thymus and peripheral Treg cells. Importantly, we found that blocking both TGF-β and IL-2 signaling impeded Nrp-1 + regulatory T cell and follicular regulatory T cell development, which led to enhanced germinal center responses.
Results
Il2ra
− / − Tg mice develop lymphadenopathy and multiorgan inflammation. Il2ra − / − Tg mice began to die at 3 weeks of age while no control mice died during observation ( Figure 1a ). They were scurfy and had ear atrophy (Supplementary Figure 1a) . Increased mononuclear cell number of peripheral lymph nodes (pLNs) and spleen in (Figure 1e ). Moreover, multiorgan inflammation mediated by T cells in Il2ra − / − Tg mice was accompanied by increased serum levels of TNF-α and IFN-γ, while IL-4 and the Th17 cytokine IL-17 were similar to littermate controls (Figure 1f ).
Increased follicular helper T cells and enhanced germinal center response in Il2ra
− / − Tg mice. As we observed lymphadenopathy and splenomegaly in Il2ra − / − Tg mice, we thought to measure the follicular helper T-cell percentage and germinal center response in this mice. We found increased percentage and cell number of Tfh cells in pLN compared Tg serum compared with littermate controls (Figure 2g ). These data suggested that antibody secreting plasma cells may play a pathogenic role in multi-organ inflammation and tissue destruction in Il2ra − / − Tg mice.
Dysregulated Treg phenotype and function in Il2ra
− / − Tg mice. Treg percentage was increased in thymus but decreased in pLN in Il2ra − / − Tg mice at 3-4 weeks of age (Figure 3a) . Increased thymus Treg cell percentage was likely due to thymus atrophy because it did not happen in 2 week Il2ra Tg mice. Treg cell phenotype can be regulated by cytokines in the microenvironment around them and further resulted in functional plasticity. 15 As a consequence of increased serum levels of TNF-α and IFN-γ in Il2ra 16 We found Ly6C expression was increased in thymus but not in Tg mice, we raised the hypothesis that increased Tfh cell and enhanced germinal center reaction in Il2ra − / − Tg mice were due to a defective Tfr development. As Tfr cells develop from thymus Treg precursors, 17 we first detected thymus Treg marker Nrp-1 expression on Treg cells. We found an almost complete loss of Nrp-1 expression on both thymus and (Figure 5g) . Deficiency of Nrp-1 and PD-1 expression on Treg cells from Il2ra − / − Tg mice was intrinsic as Treg cells from 1w and 2w Il2ra − / − Tg mice also showed decreased Nrp-1 and PD-1 expression (Supplementary Figures 2b, c, f and g) (Figures 5g and h ). These data suggested that increased Tfh cell percentage and increased germinal center reaction may due to impaired Tfr development in Il2ra 
Tg and Il2ra
− / − bone marrow as they were less competitive due to IL-2 signaling deficiency, but total Treg cell percentage were comparable after bone marrow chimera (Figure 6c ). These data indicated that Il2ra Figure 3) .
Discussion
There is no issue more critical in autoimmunity than the dissection of mechanisms that are critical for immune tolerance. 10, [18] [19] [20] [21] [22] [23] [24] [25] [26] Previous work have focused on the regulation of Treg cells, which are of crucial importance in preventing autoimmunity, by the cytokines TGF-β and IL-2. In this study, we thought to use Il2ra − / − Tg mice as a unique model to understand the synergetic role of TGF-β and IL-2 signaling on Treg cells. We found that Il2ra We studied Treg cell development and function in a circumstance that they could still receive low levels of TGF-β and IL-2 signaling in Il2ra − / − Tg mice. In Il2ra − / − mice, IL-2 can bind to its receptor β and γ to provide a low level of IL-2 signaling to Treg cells. Low IL-2 receptor signaling thresholds support the production of natural but not induced Treg cells. 27 On the other hand, there is still weak TGF-β signaling in dnTGFβRII mice, and the abrogation of TGF-β signaling in T cells can be enhanced by increasing the copy number of dnTGFβRII gene. 28 It is reported that TGF-β plays an important role in early Treg development because Lck-cre TGFβRI f/f mice had negligible Treg cells before 1 week and increased Treg percentage thereafter due to increased IL-2 signaling. 7 However, we found Treg phenotype of 1w Il2ra − / − Tg mice was similar to Il2ra − / − mice, and 1w Il2ra +/ − Tg mice had higher Treg percentage, indicating that IL-2 rather than TGF-β is important during neonatal Treg development. Besides, Treg cell percentage decreased in the periphery but increased in thymus compared with control mice at 3-4 weeks of age.
Treg cells can be activated by inflammatory cytokines. 15 IFN-γ can induce Foxp3 expression and IFN-γ stimulated Treg cells express T-bet and CXCR3, which preferentially suppress type I inflammation. 29, 30 IFN-γ or IL-27 can promote phosphorylation of STAT1 and T-bet, CXCR3, IFN-γ expression in Treg cells. 31 Treg cells from thymus and spleen can be boosted by pathogenic T-cell-secreted TNF-α but not IL-2, which may be a critical mechanism for Treg cells in preventing [32] [33] [34] However, other studies reported that the function of TGF-β induced Treg cells can be impaired by TNF-α signaling. 35 In our work, we also found an activated Treg phenotype in Il2ra − / − Tg mice. This was consistent with elevated serum concentrations of IFN-γ and TNF-α. In the absence of TGF-β signaling, Treg cells are more likely to be activated by TNF-α and maintain suppressive activity. However, thymic Treg cells from Il2ra − / − Tg mice were less activated, expressed low levels of Treg functional molecules and had less proliferation ability, resulting in decreased suppressive function in vitro.
Distinct from peripheral induced Treg cells, thymus-derived Treg cells (tTreg) have PD-1 expression. 36 PD-1/PD-L1 interaction contributes to the generation of Treg cells from naive CD4 + T cells. 37 PD-1 expressed on Treg cells can interact with PD-L1 expressed on T cells to mediate immune suppression. 24 We found that CD4 + conventional T and CD8 + T cells from Il2ra During antigen recognition, Nrp-1 expression facilitates Treg interaction with DCs to suppress T-cell activation. 38 On the other hand, semaphorin-4a ligation of Nrp-1 on Treg cells can maintain Treg stability and function through induction of PTEN. 39 Although deficiency of Nrp-1 does not affect the ability to suppress autoimmunity and maintain immune homeostasis, deficiency of Nrp-1 on Treg cells leads to enhanced immune response in tumor model. 39, 40 These suggest that Nrp-1 regulation of Treg cells needs further investigations. Nrp-1 expression on Treg cells is reported to distinguish tTreg and peripheral generated Treg cells, and is controlled by TGF-β signaling. 36, 41 However, we found that block of either TGF-β or IL-2 could decrease Nrp-1 expression on Treg cells in 1, 2 and 3 weeks of age Il2ra − / − Tg mice, and Nrp-1 expression was lost when they were both blocked. These data suggest that Nrp-1 expression on Treg cells depends on both IL-2 and TGF-β signaling, and they act in a synergistic fashion. Follicular regulatory T (Tfr) cells are a subset of Treg cells which share characteristics with Tfh cells in expressing Bcl-6 and CXCR5. Tfr develop from thymus Treg precursors and control humoral response by suppressing Tfh cell proliferation and germinal center B-cell development. 17, 42, 43 Although the transcription factor Bcl-6 is critical for Tfr differentiation, 42 little is known about mechanisms regulating their development from Treg precursors. In Il2ra − / − Tg mice, we supposed that there were no peripheral induced Treg cells in the absence of TGF-β signaling. We found that all Tfr cells were Nrp-1 + in Il2ra +/ − mice, but tTregs failed to express Nrp-1 in Il2ra
− / − Tg mice. We speculate that TGF-β and IL-2 signaling may function through regulating Bcl-6 as well as Nrp-1 expression to control Tfr differentiation but the exact molecular mechanisms needs further studies. On the other hand, we found that although Tfh percentage were comparable in Il2ra There is a balance between Th1 cells and Tfh cells. 44 Similarly, we suppose if there is a balance between Th1-like Treg cells and Tfr cells. Eomes can compensate T-bet to induce IFN-γ production in Th1 cells, and expression of Eomes in CD4 + T cells restricts peripheral Foxp3 induction. 45, 46 In our work, we reported upregulated expression of Eomes, CXCR3 on Il2ra − / − Tg Treg cells, which are associated with Th1-like Treg phenotype. In the meantime, Il2ra
− / − Tg Treg cells had decreased PD-1, Nrp-1 expression and defective ability to differentiate into Tfr cells. This indicates that TGF-β and IL-2 are important in maintaining the balance between Th1-like Treg cells and Tfr cells, blocking TGF-β and IL-2 signaling will lead to preferentially differentiation of Th1-like Treg cells and defective development of Tfr cells. In summary, our data reveal a cytokine regulation of follicular regulatory T-cell development and function, and may provide a new therapeutic target for germinal center dependent autoantibody mediated autoimmune diseases.
Material and Methods Mice. Il2ra − / − mice (B6.129S4-Il2ratm1Dw), dnTGF-βRII mice (B6.Cg-Tg (Cd4-TGFBR2)16Flv/J) and CD45.1 congenic mice on a C57BL/6 J background were obtained from Jackson Laboratory (Bar Harbor, ME). Foxp3 GFP mice (Foxp3 tm2Ayr ) were kindly provided by Dr A.Y. Rudensky. 47 dnTGF-βRII Il2ra
Tg) mice were obtained by crossing dnTGF-βRII mice with Il2ra +/ − mice. Littermates with genotypes of Il2ra − / − , dnTGF-βRII Il2ra +/ − (Il2ra +/ − Tg) and Il2ra +/ − were used as control groups. Foxp3 GFP mice were crossed to them to enable the trace of Treg cells. Il2ra − / − Tg mice and control mice were studied at 1, 2 or 3-4 weeks of age. All mice were maintained under specific pathogen-free conditions at the Laboratory Animal Center, School of Life Sciences, University of Science and Technology of China (USTC). All animal experiments were approved by the USTC Animal Care and Use Committee.
Histology. Liver, pancreas, lung and dorsal skin sections from Il2ra − / − Tg and control mice were immediately fixed in 4% paraformaldehyde after killing and embedded in paraffin. Tissue sections were then cut into 4μm slices, deparaffinized and stained with hematoxylin and eosin for microscopic examination.
Flow cytometry. Spleen, thymus, axillary, inguinal and brachial lymph nodes (pLN) were disrupted between two glass slides, suspended in PBS containing 0.2% BSA, and passed through a 74μm nylon mesh. Red blood cells were depleted using Red blood lysis buffer. Cells were then counted manually on a hemocytometer. Fluorochrome-conjugated monoclonal antibodies were used including CD45.1 (A20), CD3 (17A2), CD4 (GK1.5), NK1.1 (PK136), CD19 (6D5), CD44 (IM7), CD62L (MEL-14), CD8α (19517), CD69 (H1.2F3), GITR (YGITR765), Ly6C (HK1.4), CXCR3 (CXCR3-173), CXCR5 (L138D7), PD-1 (29F.1A12), GL7 (GL7), CD138 (281-2), Neurophilin-1 (3E12), CTLA-4 (UC10-469), Helios (22F6), Ki-67 (16A8), IFN-γ (XMG1.2) (BioLegend, San Diego, CA, USA), or CD45.2 (104), B220 (RA3-6B2), CD8α (19517) (BD biosciences, San Diego, CA, USA) and Eomes (Dan11mag), CD95 (15A7) (eBioscience, San Diego, CA, USA). The protocol for surface molecule staining and intracellular cytokine measurement were performed as described. 48 For Annexin V staining, cells were incubated with Allophycocyanin conjugated Annexin V (BioLegend) in Annexin V binding buffer (BioLegend) for 10 min after surface molecule staining, and then detected by flow cytometry. For transcription factors and CTLA-4 measurement, cells were first stained with antibodies against surface molecules, then fixed and permed using Foxp3 Staining Buffer Set (eBioscience), before antibodies against intracellular molecules were added. IgG isotype controls were used in parallel. Data were acquired using a FACSVerse flow cytometry (BD Immunocytometry Systems, San Jose, CA, USA) and analyzed with Flowjo software (Tree star, Inc., Ashland, OR, USA). /well, RPMI 1640 (Gibco, Grand island, NY, USA) supplemented with 10% FBS (Millipore, Darmstadt, Germany), 2 mM L-glutamine (Gibco), 1 mM sodium pyruvate (Gibco), 25 mM HEPES free acid (Gibco), 55 μM 2-mercaptoethanol (Gibco) and 100 U/ml Penicillin/Streptomycin (Hyclone, Logan, UT, USA)) and cultured with Treg cells at indicated ratio in the presence of soluble α-CD3 (2 μg/ml, BioLegend), α-CD28 (1 μg/ml, BioLegend) and Mitomycin C (Sigma, St Louis, MO, USA)-treated splenic supporter cells (1 × 10 5 /well) in a 96-well round bottom plate (Corning, NY, USA) for 3 days. Dead cells were excluded by DAPI staining and T-cell proliferation were assessed by CFSE dilution.
Bone marrow chimeras. Recipient CD45.1/CD45.2 mice were lethally irradiated (11 Gy) and rested for 6 h before bone marrow transplantation. 11 After depleting T cells by cell sorting using MoFlo Astrios EQ , BM cells from CD45. 4 Treg cells were extracted and bisulfite converted using EZ DNA Methylation-Direct Kit (Zymo Research, CA, USA). PCR amplification were performed using TaKaRa EpiTaq TM HS (for bisulfite treated DNA) (TaKaRa Bio Inc., Shiga, Japan). Primers for Foxp3 TSDR were forward: 5′-TTTTGGGTTT TTTTGGTATTTAAGA-3′; reverse: 5′-TTAACCAAATTTTTCTACCATTAAC-3′. The amplification conditions were 95°C for 15 s and 40 cycles of 95°C for 25 s, 55°C for 30 s, 72°C for 30 s and a final extension step of 7 min at 72°C. PCR products were separated using agarose gel, cloned into pGEM-T Vector (Promega, WI, USA) and transfected competent DH5α. 8-12 clones were picked and plasmid DNA were sequenced.
Enzyme-linked immunosorbent assay. Serum concentration of IgG1, IgG2a, IgG2b, IgG3 and IgM were detected by Ready-Set-Go! ELISA kits (eBioscience). 
